Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Organophosphorus nerve agent poisoning: managing the poisoned patient.

Hulse EJ, Haslam JD, Emmett SR, Woolley T.

Br J Anaesth. 2019 Jun 24. pii: S0007-0912(19)30401-5. doi: 10.1016/j.bja.2019.04.061. [Epub ahead of print] Review.

PMID:
31248646
2.

Group Cognitive-Behavior Therapy or Group Metacognitive Therapy for Obsessive-Compulsive Disorder? Benchmarking and Comparative Effectiveness in a Routine Clinical Service.

Papageorgiou C, Carlile K, Thorgaard S, Waring H, Haslam J, Horne L, Wells A.

Front Psychol. 2018 Dec 10;9:2551. doi: 10.3389/fpsyg.2018.02551. eCollection 2018.

3.

Sema3E/PlexinD1 inhibition is a therapeutic strategy for improving cerebral perfusion and restoring functional loss after stroke in aged rats.

Zhou YF, Li PC, Wu JH, Haslam JA, Mao L, Xia YP, He QW, Wang XX, Lei H, Lan XL, Miao QR, Yue ZY, Li YN, Hu B.

Neurobiol Aging. 2018 Oct;70:102-116. doi: 10.1016/j.neurobiolaging.2018.06.003. Epub 2018 Jun 11.

PMID:
30007159
4.

Semaphorin-3E attenuates neointimal formation via suppressing VSMCs migration and proliferation.

Wu JH, Li Y, Zhou YF, Haslam J, Elvis ON, Mao L, Xia YP, Hu B.

Cardiovasc Res. 2017 Dec 1;113(14):1763-1775. doi: 10.1093/cvr/cvx190.

PMID:
29016743
5.

S6K2-mediated regulation of TRBP as a determinant of miRNA expression in human primary lymphatic endothelial cells.

Warner MJ, Bridge KS, Hewitson JP, Hodgkinson MR, Heyam A, Massa BC, Haslam JC, Chatzifrangkeskou M, Evans GJ, Plevin MJ, Sharp TV, Lagos D.

Nucleic Acids Res. 2016 Nov 16;44(20):9942-9955. Epub 2016 Jul 12.

6.

Performance of statistical models of shape and appearance for semiautomatic segmentations of spinal vertebrae T4-L4 on digitized vertebral fracture assessment images.

van der Velde R, Ozanian T, Dumitrescu B, Haslam J, Staal J, Brett A, van den Bergh J, Geusens P.

Spine J. 2015 Jun 1;15(6):1248-54. doi: 10.1016/j.spinee.2015.02.018. Epub 2015 Feb 13.

PMID:
25684060
7.

Response to BONE-D-14-00884.

Cawthon PM, Haslam J, Fullman R, Peters KW, Black D, Ensrud KE, Cummings SR, Orwoll ES, Barrett-Connor E, Marshall L, Steiger P, Schousboe JT; Osteoporotic Fractures in Men (MrOS) Research Group.

Bone. 2015 Jun;75:246. doi: 10.1016/j.bone.2014.11.020. Epub 2014 Dec 4. No abstract available.

PMID:
25481408
8.

Methods and reliability of radiographic vertebral fracture detection in older men: the osteoporotic fractures in men study.

Cawthon PM, Haslam J, Fullman R, Peters KW, Black D, Ensrud KE, Cummings SR, Orwoll ES, Barrett-Connor E, Marshall L, Steiger P, Schousboe JT; Osteoporotic Fractures in Men (MrOS) Research Group.

Bone. 2014 Oct;67:152-5. doi: 10.1016/j.bone.2014.06.039. Epub 2014 Jul 6.

9.

Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies.

Minden MD, Hogge DE, Weir SJ, Kasper J, Webster DA, Patton L, Jitkova Y, Hurren R, Gronda M, Goard CA, Rajewski LG, Haslam JL, Heppert KE, Schorno K, Chang H, Brandwein JM, Gupta V, Schuh AC, Trudel S, Yee KW, Reed GA, Schimmer AD.

Am J Hematol. 2014 Apr;89(4):363-8. doi: 10.1002/ajh.23640. Epub 2014 Mar 3.

10.

Comprehensive vertebral deformity and vertebral fracture assessment in clinical practice: intra- and inter-reader agreement of a clinical workflow tool.

Guglielmi G, Haslam J, DʼErrico F, Steiger P, Nasuto M.

Spine (Phila Pa 1976). 2013 Dec 15;38(26):E1676-83. doi: 10.1097/BRS.0000000000000048.

PMID:
24108294
11.

Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668.

Reid JM, Walden CA, Qin R, Ziegler KL, Haslam JL, Rajewski RA, Warndahl R, Fitting CL, Boring D, Szabo E, Crowell J, Perloff M, Jong L, Bauer BA, Mandrekar SJ, Ames MM, Limburg PJ; Cancer Prevention Network.

Cancer Prev Res (Phila). 2011 Mar;4(3):347-53. doi: 10.1158/1940-6207.CAPR-10-0313.

12.

The National Ignition Facility neutron time-of-flight system and its initial performance (invited).

Glebov VY, Sangster TC, Stoeckl C, Knauer JP, Theobald W, Marshall KL, Shoup MJ 3rd, Buczek T, Cruz M, Duffy T, Romanofsky M, Fox M, Pruyne A, Moran MJ, Lerche RA, McNaney J, Kilkenny JD, Eckart MJ, Schneider D, Munro D, Stoeffl W, Zacharias R, Haslam JJ, Clancy T, Yeoman M, Warwas D, Horsfield CJ, Bourgade JL, Landoas O, Disdier L, Chandler GA, Leeper RJ.

Rev Sci Instrum. 2010 Oct;81(10):10D325. doi: 10.1063/1.3492351.

PMID:
21033848
13.

National Ignition Facility neutron time-of-flight measurements (invited).

Lerche RA, Glebov VY, Moran MJ, McNaney JM, Kilkenny JD, Eckart MJ, Zacharias RA, Haslam JJ, Clancy TJ, Yeoman MF, Warwas DP, Sangster TC, Stoeckl C, Knauer JP, Horsfield CJ.

Rev Sci Instrum. 2010 Oct;81(10):10D319. doi: 10.1063/1.3478680.

PMID:
21033845
14.

Processes of task performance as measured by the Assessment of Motor and Process Skills (AMPS): A predictor of work-related outcomes for adults with schizophrenia?

Haslam J, Pépin G, Bourbonnais R, Grignon S.

Work. 2010;37(1):53-64. doi: 10.3233/WOR-2010-1056. Review.

PMID:
20858987
15.
16.

Pharmacokinetics and enhanced bioavailability of candidate cancer preventative agent, SR13668 in dogs and monkeys.

Kapetanovic IM, Muzzio M, Hu SC, Crowell JA, Rajewski RA, Haslam JL, Jong L, McCormick DL.

Cancer Chemother Pharmacol. 2010 May;65(6):1109-16. doi: 10.1007/s00280-009-1116-4. Epub 2009 Sep 16.

PMID:
19756605
17.
18.

Customized tapered stent-grafts in the endovascular management of internal iliac artery aneurysms: a useful adjunct to conventional endovascular options.

Haslam JE, Hardman J, Horrocks M, Fay D.

Cardiovasc Intervent Radiol. 2009 Jan;32(1):139-44. doi: 10.1007/s00270-008-9425-2. Epub 2008 Sep 23.

PMID:
18810531
19.

Vaginal cones in stress incontinence treatment.

Haslam J.

Nurs Times. 2008 Feb 5-11;104(5):44-5.

PMID:
18323385
20.

A self-reported clinical trial investigates the efficacy of 1072 nm light as an anti-ageing agent.

Stirling RJ, Haslam JD.

J Cosmet Laser Ther. 2007 Dec;9(4):226-30.

PMID:
17852628
21.

N-Acylthiadiazolines, a new class of liver X receptor agonists with selectivity for LXRbeta.

Molteni V, Li X, Nabakka J, Liang F, Wityak J, Koder A, Vargas L, Romeo R, Mitro N, Mak PA, Seidel HM, Haslam JA, Chow D, Tuntland T, Spalding TA, Brock A, Bradley M, Castrillo A, Tontonoz P, Saez E.

J Med Chem. 2007 Aug 23;50(17):4255-9. Epub 2007 Aug 1.

PMID:
17665897
23.

Characterization of prednisolone in controlled porosity osmotic pump pellets using solid-state NMR spectroscopy.

Sotthivirat S, Lubach JW, Haslam JL, Munson EJ, Stella VJ.

J Pharm Sci. 2007 May;96(5):1008-17.

PMID:
17455361
24.

Evaluation of various properties of alternative salt forms of sulfobutylether-beta-cyclodextrin, (SBE)7M-beta-CD.

Sotthivirat S, Haslam JL, Stella VJ.

Int J Pharm. 2007 Feb 7;330(1-2):73-81. Epub 2006 Sep 16.

PMID:
17045435
25.

A randomized controlled trial of the effectiveness of pelvic floor therapies for urodynamic stress and mixed incontinence.

Williams KS, Assassa RP, Gillies CL, Abrams KR, Turner DA, Shaw C, Haslam J, Mayne C, McGrother CW; Leicestershire MRC Incontinence Study Team.

BJU Int. 2006 Nov;98(5):1043-50.

26.

Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.

Mell LK, Kochanski JD, Roeske JC, Haslam JJ, Mehta N, Yamada SD, Hurteau JA, Collins YC, Lengyel E, Mundt AJ.

Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1356-65. Epub 2006 Jun 6.

PMID:
16757127
27.

Preliminary evaluation of polymer-based drug composite microparticle production by coacervate desolvation with supercritical carbon dioxide.

Yasuji T, Haslam J, Kajiyama A, McIntosh MP, Rajewski RA.

J Pharm Sci. 2006 Mar;95(3):581-8.

PMID:
16419052
28.

Urinary incontinence: why women do not ask for help.

Haslam J.

Nurs Times. 2005 Nov 22-28;101(47):47-8.

PMID:
16329276
29.

Simultaneous onset of preseptal cellulitis in monozygotic twins.

Ho S, Mathew M, Haslam J.

Orbit. 2005 Mar;24(1):43-5.

PMID:
15764116
30.

Setup errors in patients treated with intensity-modulated whole pelvic radiation therapy for gynecological malignancies.

Haslam JJ, Lujan AE, Mundt AJ, Bonta DV, Roeske JC.

Med Dosim. 2005 Spring;30(1):36-42.

PMID:
15749010
31.

Home treatment for women with stress urinary incontinence.

Haslam J.

Nurs Times. 2004 Nov 30-Dec 6;100(48):56-9. Review.

PMID:
15631397
32.

The prevalence of stress urinary incontinence in women.

Haslam J.

Nurs Times. 2004 May 18;100(20):71-3. No abstract available.

PMID:
15176284
33.

Nursing management of stress urinary incontinence in women.

Haslam J.

Br J Nurs. 2004 Jan 8-21;13(1):32-40. Review.

PMID:
14966450
34.

Comparison of dose calculated by an intensity modulated radiotherapy treatment planning system and an independent monitor unit verification program.

Haslam JJ, Bonta DV, Lujan AE, Rash C, Jackson W, Roeske JC.

J Appl Clin Med Phys. 2003 Summer;4(3):224-30.

35.

Poly I:CLC induction of the interferon system in mice: an initial study of four detection methods.

Poast J, Seidel HM, Hendricks MD, Haslam JA, Levy HB, Baron S.

J Interferon Cytokine Res. 2002 Oct;22(10):1035-40.

PMID:
12433283
37.

Stability of rifabutin in two extemporaneously compounded oral liquids.

Haslam JL, Egodage KL, Chen Y, Rajewski RA, Stella V.

Am J Health Syst Pharm. 1999 Feb 15;56(4):333-6.

PMID:
10690216
38.

Design of conditionally active STATs: insights into STAT activation and gene regulatory function.

Milocco LH, Haslam JA, Rosen J, Seidel HM.

Mol Cell Biol. 1999 Apr;19(4):2913-20.

39.

Floor plan.

Haslam J.

Nurs Times. 1997 Apr 9-15;93(15):67-70. Review. No abstract available.

PMID:
9146301
40.

Continence. Working together.

Haslam J.

Nurs Times. 1996 Apr 10-16;92(15):68. No abstract available.

PMID:
8710583
41.

STAT protein complexes activated by interferon-gamma and gp130 signaling molecules differ in their sequence preferences and transcriptional induction properties.

Lamb P, Seidel HM, Haslam J, Milocco L, Kessler LV, Stein RB, Rosen J.

Nucleic Acids Res. 1995 Aug 25;23(16):3283-9.

42.

Rapid activation of the interferon-gamma signal transduction pathway by inhibitors of tyrosine phosphatases.

Lamb P, Haslam J, Kessler L, Seidel HM, Stein RB, Rosen J.

J Interferon Res. 1994 Dec;14(6):365-73.

PMID:
7897256
43.

Examination of fetuses after induced abortion for fetal abnormality--a follow-up study.

Medeira A, Norman A, Haslam J, Clayton-Smith J, Donnai D.

Prenat Diagn. 1994 May;14(5):381-5.

PMID:
8084858
44.

46,XY/47,XY, + 17p + mosaicism in amniocytes associated with fetal abnormalities despite normal fetal blood karyotype.

Kingston HM, Nicolini U, Haslam J, Andrews T.

Prenat Diagn. 1993 Jul;13(7):637-42.

PMID:
8415429
45.

De novo inverted duplication of chromosome 7q.

Haslam JS, Norman AM.

J Med Genet. 1992 Nov;29(11):837-8. No abstract available.

46.

Fetus with unbalanced translocation involving chromosomes 2 and 11.

Norman AM, Read AP, Clark A, Haslam J, Donnai D.

Clin Dysmorphol. 1992 Jan;1(1):53-6.

PMID:
1342860
47.

Daily energy expenditure in human subjects.

Haslam J, Banner M.

Biochem Soc Trans. 1991 Nov;19(4):433S. No abstract available.

PMID:
1794551
48.

Do you treat HIV positive patients?

Haslam J.

Br Dent J. 1991 Oct 19;171(8):234. No abstract available.

PMID:
1839501
49.

Survey of adolescents with severe intellectual handicap.

Asthana JC, Sinha S, Haslam JS, Kingston HM.

Arch Dis Child. 1990 Oct;65(10):1133-6.

50.

Cadmium-induced changes in renal hemodynamics in the domestic fowl.

Prashad DN, Hawkins EA, Blackburn R, Haslam J.

Experientia. 1986 Apr 15;42(4):389-90.

PMID:
3956688

Supplemental Content

Loading ...
Support Center